To curb rising HIV rates, we must target our human flaws

February 20, 2014 by John De Wit, The Conversation
Today’s global HIV statistics reflect increasingly risky sexual practices. Credit: Shutterstock

One of the most perplexing risks to public health is human nature. No matter how diligently public health campaigns lay out the facts, we continue to make seemingly illogical decisions. Just look at the obesity epidemic or binge drinking for evidence of our willingness to knowingly and repeatedly make apparently self-defeating choices; even more so when sexuality and intimacy is thrown into the mix.

In Australia, the HIV epidemic continues. Just like in other that offer high-quality, widely accessible HIV prevention, treatment and care, HIV infection rates in Australia have been steadily climbing since 1999, with the single biggest annual jump of 10% reported in 2012.

The reason is human behaviour. Optimism began to creep in when life-saving anti-retroviral therapies (ART) transformed HIV/AIDS from a certain death sentence into a manageable, if medically complex, chronic condition from the mid-1990s.

Today's global HIV statistics reflect increasingly risky sexual practices, particularly among gay men, and particularly in countries with both the resources and the political will to turn the HIV pandemic around. By contrast, many developing countries are achieving meaningful reductions in their HIV infection rates.

To date, Australia has been at the forefront of global efforts to combat the HIV epidemic since our much debated "grim reaper" campaign of the 1980s. Australia's world-class medical researchers helped develop ARTs and have made a major contribution to the use of ARTs in prevention, as the drugs drastically reduce the "viral load" in HIV positive people, so reduce the risk of transmission.

However, increasing risk-taking is outpacing these significant advances in medical science. In 2012 more than 1,200 new cases were diagnosed in Australia, bringing the estimated number of people living with HIV to 25,708.

Every new infection comes with a lifetime of medical treatment, significant risk of medical complications and considerable lifelong costs; about A$18,000 each year for ARTs for one person in Australia.

We urgently need to re-evaluate our approach and bridge the gap between that knowledge and our HIV prevention responses. That a better understanding of human behaviour will help seems obvious. But few campaigns are underpinned by rigorous behavioural and social research.

Much of what we currently do is based on common sense and past experience, which is problematic because people do not necessarily behave in their own best interests. People are, in fact, often motivated, well intentioned and well informed but suffer from the common so-called "new year's resolution" effect; they do genuinely want to change but just don't quite manage to get started or fail to maintain new behaviour.

We are also, rightly, reluctant to lecture or play on people's fears because we want them to make their own informed choices. So we assume that if we give people all the information they need they will put it together and act accordingly. But most people have more on their minds than staying healthy, and most assume they are healthy anyway.

Who hasn't been on a diet and nevertheless eaten the birthday cake because we don't want to spoil the party and surely one slice won't hurt, will it? Likewise, it's easy to imagine that sex is about many other things than avoiding HIV, particularly since HIV has become a less ominous health threat.

There are promising approaches in the behavioural sciences that go beyond limited assumptions around rational decision making and take into account everything from personal beliefs, unconscious influences and the complex "ecosystems" of signals in our environments that determine how an individual acts, even in the heat of the moment.

Some of the most important insights to emerge from the behavioural sciences in recent years reveal that simple changes can have a profound effect. Implementing an opt-out HIV testing policy at a sexual health clinic, whereby in principle everyone gets tested unless they decline, for instance, substantially increases the rates of HIV testing and so can greatly improve timely diagnosis,

One of the most powerful behavioural science strategies is to help people to make a simple action plan. This takes only a few minutes and has been found to be effective in promoting a wide range of health behaviours, including making appointments for sexual health checks, using condoms, using contraception and getting vaccinated against hepatitis B.

We have a whole range of personalised communication tools such as smart phones that can help; both with gathering information and reaching individuals with tailored health promotion approaches.

There are many human and economic reasons to reinvigorate our efforts to combat HIV. It may no longer be a fatal condition for people with access to ARTs and medical care. But this is not the same as a cure. The best reason of all is that HIV is preventable – if we effectively support people to protect themselves and others.

Explore further: Focus on undiagnosed HIV

Related Stories

Focus on undiagnosed HIV

January 20, 2014
A new study that aims to identify rates of undiagnosed HIV in Australia's gay community will offer free testing across six states and territories, including at Sydney's Gay and Lesbian Mardi Gras.

Durable end to AIDS will require HIV vaccine development

February 5, 2014
Broader global access to lifesaving antiretroviral therapies and wider implementation of proven HIV prevention strategies could potentially control and perhaps end the HIV/AIDS pandemic. However, a safe and at least moderately ...

HIV-infected women experience worse treatment outcomes after release from jail

January 22, 2014
(Medical Xpress)—A Yale study has uncovered significant gender differences in the treatment outcomes of HIV-infected jail detainees who are transitioning to life outside jail, with women faring much worse than men. The ...

Only 1 in 3 HIV-infected black Americans gets effective treatment: study

February 6, 2014
(HealthDay)—Even though drugs that can keep HIV at bay are available, only about one in three black Americans with the AIDS-causing virus have their infection under control, U.S. health officials said Thursday.

Felony HIV disclosure law criminalizes illness

December 4, 2013
Michigan's felony HIV disclosure law is driven by stigma and fear rather than medical science, according to a new University of Michigan study.

Is high blood pressure the new HIV epidemic?

February 4, 2014
High blood pressure could be as devastating to global health as HIV, a group of experts is warning.

Recommended for you

HIV-1 genetic diversity is higher in vaginal tract than in blood during early infection

January 18, 2018
A first-of-its-kind study has found that the genetic diversity of human immunodeficiency virus type 1 (HIV-1) is higher in the vaginal tract than in the blood stream during early infection. This finding, published in PLOS ...

War in Ukraine has escalated HIV spread in the country: study

January 15, 2018
Conflict in Ukraine has increased the risk of HIV outbreaks throughout the country as displaced HIV-infected people move from war-affected regions to areas with higher risk of transmission, according to analysis by scientists.

Researchers offer new model for uncovering true HIV mortality rates in Zambia

January 12, 2018
A new study that seeks to better ascertain HIV mortality rates in Zambia could provide a model for improved national and regional surveillance approaches, and ultimately, more effective HIV treatment strategies.

New drug capsule may allow weekly HIV treatment

January 9, 2018
Researchers at MIT and Brigham and Women's Hospital have developed a capsule that can deliver a week's worth of HIV drugs in a single dose. This advance could make it much easier for patients to adhere to the strict schedule ...

New long-acting, less-toxic HIV drug suppresses virus in humanized mice

January 8, 2018
A team of Yale researchers tested a new chemical compound that suppresses HIV, protects immune cells, and remains effective for weeks with a single dose. In animal experiments, the compound proved to be a promising new candidate ...

Usage remains low for pill that can prevent HIV infection

January 8, 2018
From gritty neighborhoods in New York and Los Angeles to clinics in Kenya and Brazil, health workers are trying to popularize a pill that has proven highly effective in preventing HIV but which—in their view—remains woefully ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.